Plasma

US COVID-19 blood plasma trial stopped after no benefit found

US discontinues plasma study to treat mild COVID-19, citing ‘unlikely benefit’

NIH stops Covid plasma treatment trial after researchers found no benefit

GenScript Receives Emergency Use Authorization from the FDA for Use of SARS-CoV-2 cPass (TM) Neutralizing Antibodies in Convalescent Plasma Screening

Chronic Covid-19 and convalescent plasma may increase the risk of mutation

SC Governor, First Lady donates plasma for COVID-19 therapy

South Carolina Governor, wife donates plasma for COVID-19 therapy

South Carolina Governor donates plasma for COVID-19 therapy

FDA Limits Use of Convalescent Plasma as Covid-19 Treatment

People receiving the COVID-19 vaccine can no longer administer convalescent plasma

South African coronavirus variant may decrease vaccine effectiveness, ‘evades’ plasma therapy: scientists

New variant COVID-19 defeats plasma treatment, may reduce vaccine effectiveness